Navigating NMRA Guidelines for Pharmaceutical Registration in Sri Lanka
Securing approval for pharmaceuticals in Sri Lanka requires absolute alignment with the National Medicines Regulatory Authority (NMRA). As the governing body established under the Medicines Act, the NMRA maintains strict standards to ensure the safety, efficacy, and quality of medicines imported and distributed within the country.
1. Dossier Compilation in CTD Format
Market authorization begins with compiling a comprehensive registration dossier. Sri Lanka follows the Common Technical Document (CTD) format, which compiles chemical, pharmaceutical, and biological data.
Applicants must submit detailed dossiers showing stability studies, toxicology reports, and proof of manufacturing quality. Key required documentations include:
- •Certificate of Pharmaceutical Product (CoPP) conforming to WHO guidelines.
- •Good Manufacturing Practice (GMP) certificate of the manufacturing plant.
- •Free Sale Certificate from the country of origin.
- •Complete stability data under Zone IVB conditions (30°C and 75% relative humidity).
2. Technical & Quality Evaluation
Once submitted, dossiers are evaluated by the NMRA's expert evaluation committee. This stage examines raw materials, chemical formulation stability, and packaging durability.
In many cases, samples of the formulation must be sent to the National Medicines Quality Assurance Laboratory (NMQAL) for chemical analysis to verify that the active pharmaceutical ingredients (APIs) match the label claims.
3. Local Representation & Licensing
Foreign manufacturers cannot submit applications directly to the NMRA. A local representative holding a valid Power of Attorney must act as the primary liaison.
This Colombo-based partner handles all dossier filings, resolves queries, and holds the ultimate Import License on behalf of the principal manufacturer, ensuring legal compliance at every step.
Conclusion
Navigating these guidelines successfully requires localized expertise, constant regulatory follow-ups, and proactive dossier audits. Imperial Life Sciences acts as a dedicated partner, helping global manufacturers register therapeutics in Sri Lanka with transparency.
Secure Sri Lankan Distribution
Connect with our Colombo office to consult on NMRA guidelines, port clearance logistics, and GDP warehousing setups.